Foghorn Therapeutics Inc.FHTXEarnings & Financial Report

Nasdaq · Health Care · Pharmaceutical Preparations

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.